- Investing Ideas
- /
- U.S. Biotech Stocks
U.S. Biotech Stocks
Results
443
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
443 companies
TC Biopharm (Holdings)
Market Cap: US$441.6k
A clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States.
TCBP.Y
US$0.20
7D
-16.7%
1Y
-99.8%
Regen BioPharma
Market Cap: US$436.2k
Focuses on the development of regenerative medical applications in the United States.
RGBP
US$0.014
7D
-16.7%
1Y
-83.0%
Synairgen
Market Cap: US$220.5k
Synairgen plc discovers and develops drugs for respiratory diseases.
SYGG.F
US$0.0002
7D
100.0%
1Y
-99.5%
Beroni Group
Market Cap: US$217.5k
Develops and sells smoking control products, air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics, and viral diagnostic kits in China.
BNIG.F
US$0.0064
7D
0%
1Y
n/a
Cannonau
Market Cap: US$72.5k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0002
7D
-33.3%
1Y
-88.2%
Bright Green
Market Cap: US$57.3k
Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.
BGXX.Q
US$0.0003
7D
-90.6%
1Y
-99.4%
NexImmune
Market Cap: US$13.9k
A clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States.
NEXI
US$0.0001
7D
-99.0%
1Y
-100.0%
eFFECTOR Therapeutics
Market Cap: US$2.4k
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer.
EFTR
US$0.0002
7D
0%
1Y
-99.6%
Telesis Bio
Market Cap: US$1.8k
A synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.
TBIO
US$0.012
7D
1,130.0%
1Y
-99.5%
Affimed
Market Cap: US$1.6k
A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.
AFMD.Q
US$0.000001
7D
-99.0%
1Y
-100.0%
OpGen
Market Cap: US$1.0k
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
OPGN
US$0.0001
7D
0%
1Y
-100.0%